Literature DB >> 6992319

Treatment of pulmonary embolism with prostacyclin.

T Utsunomiya, M M Krausz, C R Valeri, D Shepro, H B Hechtman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6992319

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  15 in total

Review 1.  The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsis.

Authors:  D J Bihari; J Tinker
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

2.  No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial.

Authors:  Albertus J Kooter; Richard G Ijzerman; Otto Kamp; Anco B Boonstra; Yvo M Smulders
Journal:  BMC Pulm Med       Date:  2010-03-30       Impact factor: 3.317

Review 3.  Antithrombotic therapy for pulmonary embolism.

Authors:  S Landefeld
Journal:  West J Med       Date:  1984-08

Review 4.  Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

Review 5.  Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

6.  Maintenance of cardiodynamics with aspirin during abdominal aortic aneurysmectomy (AAA).

Authors:  T Utsunomiya; M M Krausz; B Dunham; J A Mannick; P D Allen; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1981-11       Impact factor: 12.969

7.  Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.

Authors:  R I Levin; P C Harpel; D Weil; T S Chang; D B Rifkin
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

8.  Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism.

Authors:  W V Huval; M A Mathieson; L I Stemp; B M Dunham; A G Jones; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

9.  Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion.

Authors:  C Thiemermann; G R Thomas; J R Vane
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

10.  Thromboxane mediation of cardiopulmonary effects of embolism.

Authors:  T Utsonomiya; M M Krausz; L Levine; D Shepro; H B Hechtman
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.